These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7486842)

  • 1. Comparison of fluoxetine and placebo in the treatment of obesity.
    Fernández-Soto ML; González-Jiménez A; Barredo-Acedo F; Luna del Castillo JD; Escobar-Jiménez F
    Ann Nutr Metab; 1995; 39(3):159-63. PubMed ID: 7486842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine: a randomized clinical trial in the maintenance of weight loss.
    Goldstein DJ; Rampey AH; Dornseif BE; Levine LR; Potvin JH; Fludzinski LA
    Obes Res; 1993 Mar; 1(2):92-8. PubMed ID: 16350565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The addition of dexfenfluramine to fluoxetine in the treatment of obesity: a randomized clinical trial.
    Pedrinola F; Sztejnsznajd C; Lima N; Halpern A; Medeiros-Neto G
    Obes Res; 1996 Nov; 4(6):549-54. PubMed ID: 8946439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine improves insulin sensitivity in obese patients with non-insulin-dependent diabetes mellitus independently of weight loss.
    Maheux P; Ducros F; Bourque J; Garon J; Chiasson JL
    Int J Obes Relat Metab Disord; 1997 Feb; 21(2):97-102. PubMed ID: 9043962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized double blind placebo controlled crossover study of fluoxetine efficacy in the prophylaxis of chronic daily headache in children and adolescents.
    Gherpelli JL; Esposito SB
    Arq Neuropsiquiatr; 2005 Sep; 63(3A):559-63. PubMed ID: 16172700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with Binge Eating Disorder.
    Leombruni P; Pierò A; Lavagnino L; Brustolin A; Campisi S; Fassino S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1599-605. PubMed ID: 18598735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of long-term fluoxetine treatment of obesity--maximizing success.
    Goldstein DJ; Rampey AH; Roback PJ; Wilson MG; Hamilton SH; Sayler ME; Tollefson GD
    Obes Res; 1995 Nov; 3 Suppl 4():481S-490S. PubMed ID: 8697047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotoninergic manipulation, meal-induced satiety and eating pattern: effect of fluoxetine in obese female subjects.
    Lawton CL; Wales JK; Hill AJ; Blundell JE
    Obes Res; 1995 Jul; 3(4):345-56. PubMed ID: 8521151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status.
    Whigham LD; Dhurandhar NV; Rahko PS; Atkinson RL
    Int J Obes (Lond); 2007 May; 31(5):850-7. PubMed ID: 17146452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine for migraine prophylaxis: a double-blind trial.
    d'Amato CC; Pizza V; Marmolo T; Giordano E; Alfano V; Nasta A
    Headache; 1999; 39(10):716-9. PubMed ID: 11279947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 12-month follow-up of fluoxetine and cognitive behavioral therapy for binge eating disorder.
    Grilo CM; Crosby RD; Wilson GT; Masheb RM
    J Consult Clin Psychol; 2012 Dec; 80(6):1108-13. PubMed ID: 22985205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine: a randomized clinical trial in the treatment of obesity.
    Goldstein DJ; Rampey AH; Enas GG; Potvin JH; Fludzinski LA; Levine LR
    Int J Obes Relat Metab Disord; 1994 Mar; 18(3):129-35. PubMed ID: 8186809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine's effect on weight loss in obese subjects.
    Darga LL; Carroll-Michals L; Botsford SJ; Lucas CP
    Am J Clin Nutr; 1991 Aug; 54(2):321-5. PubMed ID: 1858696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine treatment of the obese diabetic.
    Gray DS; Fujioka K; Devine W; Bray GA
    Int J Obes Relat Metab Disord; 1992 Mar; 16(3):193-8. PubMed ID: 1317828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.
    Robinson RG; Schultz SK; Castillo C; Kopel T; Kosier JT; Newman RM; Curdue K; Petracca G; Starkstein SE
    Am J Psychiatry; 2000 Mar; 157(3):351-9. PubMed ID: 10698809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study.
    Suvanto-Luukkonen E; Koivunen R; Sundström H; Bloigu R; Karjalainen E; Häivä-Mällinen L; Tapanainen JS
    Menopause; 2005; 12(1):18-26. PubMed ID: 15668596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label pilot study of the combination therapy of metformin and fluoxetine for weight reduction.
    Dastjerdi MS; Kazemi F; Najafian A; Mohammady M; Aminorroaya A; Amini M
    Int J Obes (Lond); 2007 Apr; 31(4):713-7. PubMed ID: 16969361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity.
    Smith IG; Goulder MA;
    J Fam Pract; 2001 Jun; 50(6):505-12. PubMed ID: 11407998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is fluoxetine an effective therapy for weight loss in obese patients?
    Epling J;
    Am Fam Physician; 2003 Dec; 68(12):2437-8. PubMed ID: 14705765
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term effects of fluoxetine on glycemic control in obese patients with non-insulin-dependent diabetes mellitus or glucose intolerance: influence on muscle glycogen synthase and insulin receptor kinase activity.
    Breum L; Bjerre U; Bak JF; Jacobsen S; Astrup A
    Metabolism; 1995 Dec; 44(12):1570-6. PubMed ID: 8786726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.